Anthropic, PBC (ANT) financial model — FocusAlpha
Three-statement model of Anthropic, PBC (ANT): income statement, balance sheet, cash flow, segments and valuation, every reported figure linked to its filing. Key numbers: revenue (USD m) FY2024 386, FY2025 4,585, FY2026E 43,365, FY2027E 98,217, FY2028E 149,024; Non-GAAP EPS – diluted FY2026E 3.82; target price 982.03. Built by FocusAlpha Model Builder; version f47698c of 2026-10-30.
Income statement (USD m; margins and growth in %, EPS per share; negatives in parentheses; - = zero; E = model forecast)| Line | FY2024 | FY2025 | FY2026E | FY2027E | FY2028E |
|---|
| Revenue | 386 | 4,585 | 43,365 | 98,217 | 149,024 |
|---|
| Revenue YoY | 841.5% | 1087.8% | 845.8% | 126.5% | 51.7% |
|---|
| Operating income | (2,980) | (8,060) | 1,590 | 8,280 | 12,563 |
|---|
| Operating margin | (772.0%) | (175.8%) | 3.7% | 8.4% | 8.4% |
|---|
| Net income | (8,309) | (41,965) | (78,945) | 6,541 | 9,925 |
|---|
| EPS – diluted | (5.43) | (23.04) | (43.35) | 3.59 | 5.45 |
|---|
| Non-GAAP EPS – diluted | (1.75) | (2.44) | 3.82 | 6.33 | 8.18 |
|---|
Segment revenue (USD m; margins and growth in %, EPS per share; negatives in parentheses; - = zero; E = model forecast)| Line | FY2024 | FY2025 | FY2026E | FY2027E | FY2028E |
|---|
| Geography – revenue | | | | | |
|---|
| United States | 263 | 3,362 | | | |
|---|
| International | 123 | 1,223 | | | |
|---|
| Pricing model – revenue | | | | | |
|---|
| Consumption-based | 288 | 3,796 | | | |
|---|
| Subscription-based | 98 | 789 | | | |
|---|
Valuation| Line | Value |
|---|
| Non-GAAP EPS, next four quarters (model) — the basis of consensus and the P/E | 5.15 |
|---|
| Q3 FY26E | 1.15 |
|---|
| Q4 FY26E | 1.20 |
|---|
| Q1 FY27E | 1.32 |
|---|
| Q2 FY27E | 1.47 |
|---|
| Revenue per share, next four quarters (model) | 36.33 |
|---|
| Price / sales (assumption) | 12.0x |
|---|
| Target price | 435.99 |
|---|
| Price / sales at the offering midpoint (check) | - |
|---|
| GAAP EPS, next four quarters (model) — for reference | 2.42 |
|---|
| Price / sales | 982.03 |
|---|
| Weight — P/E | - |
|---|
| Weight — Price / sales | 100.0% |
|---|
| Blended target price | 982.03 |
|---|
| Weights add up to | 100.0% |
|---|
| Revenue vs the model – first forecast year | - |
|---|
| Revenue vs the model – later years | - |
|---|
| EBIT and EBITDA margin vs the model (points) | - |
|---|
| Multiple vs the base multiple | 1.00x |
|---|
| Revenue: revenue vs the model, on top of the above | - |
|---|
| Revenue | 66,162 |
|---|
| Depreciation and amortization | 576 |
|---|
| EBIT (operating income) | 5,577 |
|---|
| EBITDA | 6,153 |
|---|
| Effective tax rate | 21.0% |
|---|
| Net income | 4,406 |
|---|
| Diluted shares (m) | 1,821.0 |
|---|
| Non-GAAP diluted EPS | 5.15 |
|---|
| Capital expenditure | (1,892) |
|---|
| Working capital and other | (3,612) |
|---|